Effect of GH on the Blastocyst Euploid Rate in AMA Patients
NCT05447208 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 400
Last updated 2025-02-12
Summary
This randomized trial aims to compare the euploid rate of blastocysts in AMA patients undergoing PGT-A (preimplantation genetic testing for aneuploidy) with or without growth hormone supplement.
Infertile patients ≥38 years old will be recruited for study after informed consent if they fulfill the inclusion criteria and do not have the exclusion criteria. Eligible women will be randomised into one of the two groups:
Treatment group: Women will receive growth hormone (GH) supplement before and during antagonist protocol for ovarian stimulation.
Control group: Women will receive antagonist protocol for ovarian stimulation. The primary outcome is the euploidy rate of blastocysts.
Conditions
- Preimplantation Genetic Testing
- Growth Hormone
- Age, Parental
Interventions
- DRUG
-
Growth Hormone
Growth hormone is supplemented before and during the ovarian stimulation till the day of oocyte retrieval
- DRUG
-
GnRH antagonist
GnRH antagonist (Cetrorelix 0.25mg) once subcutaneously daily from day 6 of ovarian stimulation till the day of the ovulation trigger
Sponsors & Collaborators
-
ShangHai Ji Ai Genetics & IVF Institute
lead OTHER
Principal Investigators
-
XIAOXI SUN, PhD · Shanghai JiAi Genetics & IVF Institute, China
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 38 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-01
- Primary Completion
- 2026-03-01
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles
NCT02908438 ·Status: UNKNOWN ·Phase: PHASE1
-
A Randomized Controlled Study of Prolonging the Time of Progesterone Supplementation to Improve the Pregnancy Outcome of Single Day 6 Blastocyst Transfer of Freeze-thaw Cycle
NCT04938011 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Intrauterine Injection of HCG on Pregnancy Outcome in Repeated Implantation Failure Patients
NCT02870855 ·Status: WITHDRAWN ·Phase: NA
-
Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response
NCT04414761 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.
NCT05980091 ·Status: RECRUITING ·Phase: PHASE1
-
GnRH Agonist at Embryo Transfer: IVF Outcomes
NCT03544073 ·Status: WITHDRAWN ·Phase: PHASE3
-
Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles
NCT05340010 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF
NCT03680053 ·Status: TERMINATED ·Phase: NA
-
An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients
NCT05569577 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment
NCT00948805 ·Status: UNKNOWN ·Phase: PHASE3
-
HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients
NCT03578172 ·Status: COMPLETED ·Phase: NA
-
Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration
NCT02330770 ·Status: RECRUITING ·Phase: PHASE4
-
Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment
NCT07128394 ·Status: RECRUITING ·Phase: NA
-
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
NCT04064840 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
NCT03071172 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders
NCT03759301 ·Status: COMPLETED ·Phase: PHASE4
-
To Explore the Effect of GH Pretreatment on Clinical Outcomes in Patients With Low Ovarian Reserve
NCT04384783 ·Status: UNKNOWN
-
HOPE Trial hCG or Progesterone Effect on Recurrent Pregnancy Loss
NCT05365464 ·Status: WITHDRAWN ·Phase: PHASE2
-
Antagonist Protocol in Poor Responders
NCT02195947 ·Status: COMPLETED ·Phase: PHASE4
-
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
NCT07216742 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of GH Administration in Poor Responders Undergoing Intracytoplasmic Sperm Injection (ICSI)
NCT05281341 ·Status: COMPLETED ·Phase: PHASE4
-
GnRH Agonist for Luteal Phase Support.
NCT05484193 ·Status: UNKNOWN ·Phase: NA
-
A Study of Human Chorionic Gonadotrophin as Luteal Phase Support in Frozen Embryo Transfer
NCT01931384 ·Status: COMPLETED ·Phase: NA
-
Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a
NCT05143723 ·Status: UNKNOWN ·Phase: PHASE2
-
Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support
NCT05286554 ·Status: COMPLETED ·Phase: PHASE4